By Balambal Suryanarayanan CRISPR-Cas9 is a repurposed gene editing tool that allows scientists to cut, replace, and insert pieces of DNA in precise regions along the strand. Courtesy of NIH Image ...

Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my ...

Argonne computer scientists enabled a new research modality in the search for causality among genetic variants for a given ...

MUSC health has established the Rena N. Grant Sickle Cell Center to help treat those suffering from sickle cell disease. This ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...

This makes it difficult for those with Sickle Cell Anemia, who are of African descent. “Many of those patients require up to 100 transfusions of blood every single year. It’s a very painful ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...